CANSLIM Stock Screener – 2026-09-19 (141 Stocks)

The 141 names passing the CAN SLIM stock screener cluster heavily in a few software and chip groups. Software – Infrastructure leads with 28 stocks, followed by Software – Application at 23 and Semiconductors at 15. That means roughly half of the entire list sits in just three related industries, a clear sign of where leadership is currently concentrated.

Ten names appear on two or more of the screens run, which is the strongest form of cross-confirmation in this data set: AMD, NET, NTAP, SNOW, ANET, AVT, DELL, ECO, P, and PLTR. Separately, the roster of CANSLIM stocks rotated noticeably versus the prior session, with 26 new entrants including ARM, MU, MSTR, ROKU, and COHR, while 13 names such as MRVL, VEEV, PAY, and TECK dropped out. That churn suggests the list is being refreshed by fresh momentum rather than static leadership.

Among the names selected by all three screens, AMD is in an Advancing phase with a rising wedge pattern and a mature base: 26.1% deep, 11.4 weeks in formation, and a pivot at $580.91. NET is also Advancing with a rising wedge, but its base is immature at 0.0% depth and only 0.2 weeks formed, with a pivot at $333.94. NTAP is Advancing in a VCP pattern with a mature base, 12.7% deep over 5.0 weeks and a pivot at $207.08, while SNOW is Advancing in a deep base that is not yet mature, 9.4% deep over 2.0 weeks with a pivot at $356.47. The contrast between mature structures like AMD and NTAP and the very early bases at NET and SNOW is the key distinction in this group.

For educational purposes only — not investment advice.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.